Germany, Nov. 17 -- Evonik has entered a strategic partnership with InVitria, a leading developer of recombinant proteins and supplements, to supply animal component-free (ACF) recombinant human serum albumin to the global biopharmaceutical industry. The collaboration brings together Evonik's global reach and expertise in cell culture ingredients with InVitria's advanced recombinant production technology. It also enables more customers to access high-quality, animal-free ingredients that enhance process efficiency and product stability across cell culture and biologics formulations. Evonik will distribute InVitria's blood-free recombinant human serum albumin (rHSA) portfolio to its biopharma customers. InVitria's rHSA is a highly pure recom...